Ju Fu Tang Biotech Holdings Co., Ltd (HKG:8217)

HKG:8217 Balance Sheet

Financials in millions HKD. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	9.28	2.11	4.01	8.15	8.2
Trading Asset Securities	51.38	28.06	22.71	36.06	36.5
Cash & Short-Term Investments	60.65	30.17	26.72	44.22	44.7
Cash Growth	101.02%	12.94%	-39.58%	-1.08%	-6.30%
Accounts Receivable	22.34	39.62	48.08	54.76	89.75
Other Receivables	4.53	0.97	1.49	1.52	1.99
Receivables	26.87	40.59	49.56	56.28	91.74
Other Current Assets	5.09	9.44	5.03	4.7	6.55
Total Current Assets	92.61	80.2	81.31	105.19	143
Property, Plant & Equipment	-	0.16	0.24	0.32	0.68
Other Long-Term Assets	-	-	-	-	0.67
Total Assets	92.61	80.37	81.55	105.51	144.35

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	9.17	11.72	12.67	10.01	8.61
Accrued Expenses	6.2	6.07	6.48	5.76	3.76
Short-Term Debt	-	2.26	2.26	10.03	42.96
Current Portion of Long-Term Debt	12	12	12	12	12
Current Portion of Leases	-	-	-	-	0.16
Current Income Taxes Payable	0.63	0.63	0.63	0.63	0.63
Current Unearned Revenue	0.27	1.52	1.52	1.52	3.4
Other Current Liabilities	13.8	18.96	12.88	15.01	12.32
Total Current Liabilities	42.08	53.15	48.44	54.96	83.83
Total Liabilities	42.08	53.15	48.44	54.96	83.83

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	48.3	48.3	48.3	48.3	48.3
Additional Paid-In Capital	-	60.7	60.7	60.7	60.7
Retained Earnings	-	-98.56	-96.13	-78.69	-69.16
Comprehensive Income & Other	2.24	16.79	20.25	20.25	20.68
Shareholders' Equity	50.54	27.22	33.12	50.55	60.51
Total Liabilities & Equity	92.61	80.37	81.55	105.51	144.35

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	12	14.26	14.26	22.03	55.12
Net Cash (Debt)	48.65	15.91	12.45	22.18	-10.42
Net Cash Growth	205.84%	27.77%	-43.87%	-	-
Net Cash Per Share	0.16	0.05	0.04	0.07	-0.05
Filing Date Shares Outstanding	301.86	301.86	301.86	301.86	301.86
Total Common Shares Outstanding	301.86	301.86	301.86	301.86	301.86
Working Capital	50.54	27.06	32.87	50.23	59.16
Book Value Per Share	0.17	0.09	0.11	0.17	0.20
Tangible Book Value	50.54	27.22	33.12	50.55	60.51
Tangible Book Value Per Share	0.17	0.09	0.11	0.17	0.20
Land	-	1.61	1.61	1.61	1.61
Machinery	-	-	-	8.29	18.99
Order Backlog	394.23	346.89	333.84	287.29	478.92

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 1, 2026

Data Sources Report a data error